Overview

Safety and Pharmacokinetics Study of amlodipine10mg and candesartan32mg

Status:
Completed
Trial end date:
2013-08-01
Target enrollment:
Participant gender:
Summary
Clinical trial to evalate the pharmacokinetic interactions and safety between single dose of amlodipine10mg and candesartan32mg and combiation dose amlodipine10mg with candesartan32mg in healthy male volunteers.
Phase:
Phase 1
Details
Lead Sponsor:
HanAll BioPharma Co., Ltd.
Treatments:
Amlodipine
Candesartan
Candesartan cilexetil